Business
RavenQuest Begins Trading on Frankfurt Exchange Under Symbol “1IT”
RavenQuest Begins Trading on Frankfurt Exchange Under Symbol “1IT”.
About this update from Ravenquest Biomed Inc
[{"type":"text","content":"\n\n VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) is pleased to announce that it has commenced trading on the Frankfurt Stock Exchange with immediate effect.  RavenQuest’s common shares commenced trading under the symbol “1IT”.\n RavenQuest CEO, George Robinson, stated that “trading on the Frankfurt Exchange gives our capital markets exposure to a truly global reach, providing ease of access, transparency and peace of mind for European and international investors.  Truly global companies have a presence in Europe and we are very excited for our company to have this listing.” “The Cannabis Act federally legalizes the adult recreational use of cannabis in Canada.  Having passed through the House of Commons, the bill is now in the final stages of the legislative process.  Canada’s cannabis-friendly investment climate is a unique opportunity in this rapidly growing segment of the global economy, and RavenQuest is an even more unique company within the Canadian cannabis sector.  Our focus upon Indigenous communities, our game-changing grow technology, our plant optimization science and our management services all allow for diversified revenue streams and tremendous growth potential.  We welcome every opportunity to share our story with the world, and a Frankfurt listing is a big step in that direction,” Robinson continued. RavenQuest will continue to trade on the Canadian Securities Exchange (CSE) under the symbol “RQB” and the OTCQB under the symbol “RVVQF”. About RavenQuest BioMed Inc. RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services and consulting, and specialized research and development. On Behalf of the Board of Directors of RAVENQUEST BIOMED INC. \"George Robinson\"Chief Executive Officer For further information, please contact:Mathieu McDonald, Corporate Communications 604-484-1230 Cautionary Note Regarding Forward-Looking Statements All statements in this press release, other than statements of historical fact, are \"forward-looking information\" with respect to the Company within the meani...